Physician profile
Robert Kadish
NPI 1639190366
$4,229.28
in general payments reported to CMS, 2019-2025
23 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $911 · 2021: $988 · 2022: $314 · 2023: $237 · 2024: $476 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,353.09 | 2020-2025 | |
| Smith+Nephew, INC. | $791.01 | 2019-2024 | Collagenase Santyl, Regranex, Stravix |
| Alon Medical Technology | $540.42 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $353.77 | 2021-2025 | Nuzyra |
| Stryker Corporation | $215.22 | 2019-2025 | Prostep Mica, Ortholoc 2 Lapifuse |
| Organogenesis INC. | $196.46 | 2024-2025 | Puraply Wound Matrix |
| Vaporox, INC. | $118.30 | 2023 | Vht-200 Wound Treatment System |
| Nevro Corp. | $89.60 | 2022-2023 | Senza |
| Ibsa Pharma INC. | $85.77 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $68.85 | 2020-2021 | |
| Abbvie INC. | $67.94 | 2021-2025 | |
| Bioventus LLC | $62.14 | 2019-2025 | Xcell |
| Amgen INC. | $47.42 | 2025 | Krystexxa |
| Voom Medical Devices, INC. | $40.42 | 2024 | Revcon |
| Kerecis Limited | $39.61 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $30.85 | 2024-2025 | |
| Horizon Therapeutics Plc | $30.57 | 2022 | |
| Wright Medical Technology, INC. | $24.27 | 2019-2020 | |
| Grt US Holding, INC. | $22.75 | 2022 | |
| Alfasigma USA, INC. | $16.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.30 | 2022 | |
| Nabriva Therapeutics, Plc | $11.38 | 2021 | |
| Melinta Therapeutics, LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kadish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.